BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 34234121)

  • 1. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex.
    Lam MMC; Wick RR; Watts SC; Cerdeira LT; Wyres KL; Holt KE
    Nat Commun; 2021 Jul; 12(1):4188. PubMed ID: 34234121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia.
    Wyres KL; Nguyen TNT; Lam MMC; Judd LM; van Vinh Chau N; Dance DAB; Ip M; Karkey A; Ling CL; Miliya T; Newton PN; Lan NPH; Sengduangphachanh A; Turner P; Veeraraghavan B; Vinh PV; Vongsouvath M; Thomson NR; Baker S; Holt KE
    Genome Med; 2020 Jan; 12(1):11. PubMed ID: 31948471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing.
    Zautner AE; Bunk B; Pfeifer Y; Spröer C; Reichard U; Eiffert H; Scheithauer S; Groß U; Overmann J; Bohne W
    J Antimicrob Chemother; 2017 Oct; 72(10):2737-2744. PubMed ID: 29091199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Carbapenemase-Producing
    Granov D; Dedeić-Ljubović A; Salimović-Bešić I
    Microb Drug Resist; 2020 Sep; 26(9):1038-1045. PubMed ID: 32208954
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic and Molecular Characterization of Multidrug Resistant Klebsiella pneumoniae Isolated from Different Clinical Sources in Al-Najaf Province-Iraq.
    Aljanaby AAJ; Alhasnawi HMRJ
    Pak J Biol Sci; 2017; 20(5):217-232. PubMed ID: 29023034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity, virulence, and antimicrobial resistance of the KPC-producing
    Villa L; Feudi C; Fortini D; Brisse S; Passet V; Bonura C; Endimiani A; Mammina C; Ocampo AM; Jimenez JN; Doumith M; Woodford N; Hopkins K; Carattoli A
    Microb Genom; 2017 Apr; 3(4):e000110. PubMed ID: 28785421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of KPC-2-Producing
    Su S; Li C; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Zhang J; Zhang X
    Microb Drug Resist; 2020 Sep; 26(9):1009-1018. PubMed ID: 32150494
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection.
    Shankar C; Veeraraghavan B; Nabarro LEB; Ravi R; Ragupathi NKD; Rupali P
    BMC Microbiol; 2018 Jan; 18(1):6. PubMed ID: 29433440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.
    Mahmoudi S; Pourakbari B; Rahbarimanesh A; Abdosalehi MR; Ghadiri K; Mamishi S
    Infect Disord Drug Targets; 2019; 19(1):46-54. PubMed ID: 29732983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
    Nishida S; Ono Y
    Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
    Gomez-Simmonds A; Uhlemann AC
    J Infect Dis; 2017 Feb; 215(suppl_1):S18-S27. PubMed ID: 28375514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health.
    Holt KE; Wertheim H; Zadoks RN; Baker S; Whitehouse CA; Dance D; Jenney A; Connor TR; Hsu LY; Severin J; Brisse S; Cao H; Wilksch J; Gorrie C; Schultz MB; Edwards DJ; Nguyen KV; Nguyen TV; Dao TT; Mensink M; Minh VL; Nhu NT; Schultsz C; Kuntaman K; Newton PN; Moore CE; Strugnell RA; Thomson NR
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3574-81. PubMed ID: 26100894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
    Harada S; Aoki K; Yamamoto S; Ishii Y; Sekiya N; Kurai H; Furukawa K; Doi A; Tochitani K; Kubo K; Yamaguchi Y; Narita M; Kamiyama S; Suzuki J; Fukuchi T; Gu Y; Okinaka K; Shiiki S; Hayakawa K; Tachikawa N; Kasahara K; Nakamura T; Yokota K; Komatsu M; Takamiya M; Tateda K; Doi Y
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
    Tamma PD; Fan Y; Bergman Y; Pertea G; Kazmi AQ; Lewis S; Carroll KC; Schatz MC; Timp W; Simner PJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
    Mills RO; Dadzie I; Le-Viet T; Baker DJ; Addy HPK; Akwetey SA; Donkoh IE; Quansah E; Semanshia PS; Morgan J; Mensah A; Adade NE; Ampah EO; Owusu E; Mwintige P; Amoako EO; Spadar A; Holt KE; Foster-Nyarko E
    J Antimicrob Chemother; 2024 Jul; 79(7):1529-1539. PubMed ID: 38751093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a retrospective clinical study.
    Cuénod A; Wüthrich D; Seth-Smith HMB; Ott C; Gehringer C; Foucault F; Mouchet R; Kassim A; Revathi G; Vogt DR; von Felten S; Bassetti S; Tschudin-Sutter S; Hettich T; Schlotterbeck G; Homberger C; Casanova C; Moran-Gilad J; Sagi O; Rodríguez-Sánchez B; Müller F; Aerni M; Gaia V; van Dessel H; Kampinga GA; Müller C; Daubenberger C; Pflüger V; Egli A
    Genome Med; 2021 Sep; 13(1):150. PubMed ID: 34517886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Relatedness of NDM-Producing
    Flores C; Bianco K; de Filippis I; Clementino MM; Romão CMCPA
    Microb Drug Resist; 2020 Oct; 26(10):1219-1226. PubMed ID: 32283041
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.
    Gaiarsa S; Comandatore F; Gaibani P; Corbella M; Dalla Valle C; Epis S; Scaltriti E; Carretto E; Farina C; Labonia M; Landini MP; Pongolini S; Sambri V; Bandi C; Marone P; Sassera D
    Antimicrob Agents Chemother; 2015 Jan; 59(1):389-96. PubMed ID: 25367909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.